BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29605467)

  • 1. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers.
    Primavera R; Palumbo P; Celia C; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L; Cilurzo F
    Eur J Pharm Biopharm; 2018 Jun; 127():432-442. PubMed ID: 29605467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
    Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2.
    Watanabe K; Sawano T; Endo T; Sakata M; Sato J
    Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
    Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
    J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" [Eur. J. Pharm. Biopharm. 127 (2018) 432-442].
    Primavera R; Palumbo P; Celia C; Cilurzo F; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L
    Eur J Pharm Biopharm; 2018 Jul; 128():259. PubMed ID: 29738716
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
    Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
    Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.
    Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial transport of putrescine across monolayers of the human intestinal epithelial cell line, Caco-2.
    Milovic V; Turchanowa L; Stein J; Caspary WF
    World J Gastroenterol; 2001 Apr; 7(2):193-7. PubMed ID: 11819759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid and docosahexaenoic acid cause an increase in the paracellular absorption of hydrophilic compounds in an experimental model of human absorptive enterocytes.
    Aspenström-Fagerlund B; Ring L; Aspenström P; Tallkvist J; Ilbäck NG; Glynn AW
    Toxicology; 2007 Jul; 237(1-3):12-23. PubMed ID: 17560003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
    Dimitrijevic D; Shaw AJ; Florence AT
    J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models and methods to evaluate transport of drug delivery systems across cellular barriers.
    Ghaffarian R; Muro S
    J Vis Exp; 2013 Oct; (80):e50638. PubMed ID: 24192611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: correlation with membrane transport and transepithelial secretion.
    Lowes S; Simmons NL
    Pflugers Arch; 2001 Nov; 443(2):265-73. PubMed ID: 11713653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.